J&J Raises Forecast as Demand for New Drugs Boosts Profit

Johnson & Johnson, the world’s biggest maker of health-care products, beat expectations and raised its 2014 forecast by focusing on new drugs and reducing its reliance on medical devices.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.